{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:05Z","timestamp":1791357485261,"version":"4.3.1"},"reference-count":75,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuropsychiatric symptoms of hyperammonaemia include alterations of mood and personality, cognitive impairment, ataxia, convulsions and coma. The nature and severity of CNS dysfunction depend upon the aetiology and degree of hyperammonaemia, its acuteness of onset and the age of the patient. Neuropathological studies reveal Alzheimer type II astrocytosis in the adult hyperammonaemic patient, whereas hyperammonaemia in the infant resulting from congenital urea cycle disorders or Reye syndrome is accompanied by cerebral atrophy, neuronal loss and cerebral oedema. Several electrophysiological and biochemical mechanisms have been proposed to explain the deleterious effects of ammonia on CNS function. Such mechanisms include direct effects of the ammonium ion on excitatory and inhibitory neurotransmission and a deficit in cerebral energy metabolism due to ammonia\u2010induced inhibition of \u03b1\u2010ketoglutarate dehydrogenase. In addition, ammonia has been shown to interfere with normal processes of uptake, storage and release of various neurotransmitters. Ammonia disrupts monoamine storage, inhibits the high\u2010affinity uptake of glutamate by both astrocytic and neuronal elements and activates \u2018peripheral\u2010type\u2019 benzodiazepine receptors leading to the potential synthesis of neuroactive steroids in brain. On the basis of these actions, it has been proposed that ammonia disrupts neuron\u2010astrocyte trafficking of amino acids and monoamines in brain. The increased formation of brain glutamine in hyperammonaemic syndromes could be responsible for the phenomenon of brain oedema in these disorders. Therapies aimed at either decreasing ammonia production in the gastrointestinal tract or increasing ammonia removal by liver or skeletal muscle are the mainstay in the prevention and treatment of the CNS consequences of hyperammonaemia. New therapeutic approaches aimed at correction of the neurotransmitter and cerebral energy deficits in these syndromes could hold promise for the future.<\/jats:p>","DOI":"10.1023\/a:1005393104494","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T21:48:34Z","timestamp":1040507314000},"page":"6-20","source":"Crossref","is-referenced-by-count":119,"title":["Effects of hyperammonaemia on brain function"],"prefix":"10.1002","volume":"21","author":[{"given":"R. F.","family":"Butterworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1998,6]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-198404000-00014"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb07300.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02527755"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00964814"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb08842.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(96)00037-5"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)73788-0"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190619"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(90)90029-5"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-407-02312-3.50012-0"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000111350"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1988.tb01064.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb02041.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02833601"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00339-9"},{"key":"e_1_2_1_17_1","first-page":"10","article-title":"Severe cerebral damage in ornithine transcarbamylase deficiency","volume":"7","author":"Dolman CL","year":"1988","journal-title":"Clin Neuropathol"},{"key":"e_1_2_1_18_1","unstructured":"EllisAJ ProudfootD WendonJA WilliamsR(1997)A controlled trial of phenytoin infusion in ALF. Does subclinical fitting cause cerebral oedema? (Abstract).J Hepatol107.."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1987.tb10018.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)91157-N"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80935-0"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)91222-Z"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01300297"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-198507000-00003"},{"key":"e_1_2_1_25_1","first-page":"205","volume-title":"Advances Hepatic Encephalopathy and Metabolism in Liver Disease","author":"Ha J\u2010H","year":"1997"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00572763"},{"key":"e_1_2_1_27_1","first-page":"601","volume-title":"Greenfield's Neuropathology","author":"Harper CG","year":"1997"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1341001"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108651"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90038-8"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.46.1.28"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00444-8"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1986.tb00768.x"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110524"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1991.66"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02336140"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)80404-5"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1995.tb01036.x"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00236570"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI102862"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1961.200.3.420"},{"key":"e_1_2_1_42_1","first-page":"259","article-title":"Pathologic concentrations of ammonium ions block L\u2010glutamate uptake","volume":"59","author":"Mena EE","year":"1983","journal-title":"Exp Neurol"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02674610"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250323"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240425"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1983.tb08057.x"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1979.tb09913.x"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02833599"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220227"},{"key":"e_1_2_1_50_1","first-page":"222","article-title":"Peripheral\u2010type benzodiazepine\/diazepam binding inhibitor receptor: biological role in steroidogenic cell function","volume":"14","author":"Papadopoulos V","year":"1993","journal-title":"Endocrine Rev"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb04149.x"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1972.223.5.1143"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4506-3_3"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01000437"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90208-9"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199312000-00016"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)90653-3"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90290-9"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01996073"},{"key":"e_1_2_1_60_1","first-page":"437","article-title":"Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: therapeutic effect of acetyl\u2010L\u2010carnitine","volume":"274","author":"Ratnakumari L","year":"1995","journal-title":"J Pharmacol Exp T her"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02081030"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199607000-00005"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb09356.x"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90038-8"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00996975"},{"key":"e_1_2_1_66_1","first-page":"215","article-title":"Peripheral benzodiazepine receptor ligands induce morphological changes in mitochondria of cultured glioma cells","volume":"16","author":"Shiraishi T","year":"1990","journal-title":"Soc Neurosci Abstr"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1500113"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(92)90008-3"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150316"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5319.1699"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200511"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00996922"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00972136"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250406"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02866030"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.38.4.322"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1023%2FA%3A1005393104494","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1023\/A%3A1005393104494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T19:14:17Z","timestamp":1694805257000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1023\/A%3A1005393104494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":75,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1023\/A:1005393104494"],"URL":"https:\/\/doi.org\/10.1023\/a:1005393104494","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}